The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial

BACKGROUND: Assessing genetic lifetime risk for prostate cancer has been proposed as a means of risk stratification to identify those for whom prostate-specific antigen (PSA) testing is likely to be most valuable. This project aimed to test the effect of introducing a genetic test for lifetime risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Fredsøe, Jacob, Koetsenruyter, Jan, Vedsted, Peter, Kirkegaard, Pia, Væth, Michael, Edwards, Adrian, Ørntoft, Torben F., Sørensen, Karina D., Bro, Flemming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006905/
https://www.ncbi.nlm.nih.gov/pubmed/32032355
http://dx.doi.org/10.1371/journal.pmed.1003033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006905/
https://www.ncbi.nlm.nih.gov/pubmed/32032355
http://dx.doi.org/10.1371/journal.pmed.1003033

Ejemplares similares